| |
I
W P C P S® 8
Eighth
International Workshop on Physical Characterization of Pharmaceutical
Solids
The IWPCPS®-8 will be held June 18 - 24, 2006 in one of the most historical places on earth
Rhodes, Greece
At Sofitel Capsis Hotel Rhodes & Convention Centre " Marika Capsis 2000"
Ixia, Rhodes
New Topics such as:
- Bioavailability of Forms
- Generation of Forms
- Characterization of Forms
- PAT – Process Analytical Technology
- Characterization and Quality Control of Drug Product
- Dissolution of Forms and Drug Product
General Topics such as:
- Polymorphs and Solvates
- Special XRD Applications
- Modern Thermal Analysis Applications
- Solid State NMR Applications
- Amorphous Content _ Determination And Characterization
- Particle Size Analysis And Processing Effects
- Morphology And Surface Characterization
- Drug Product Characterization
- Regulatory Patent Issues
The International Workshops on Physical Characterization of Pharmaceutical Solids has a five year history now.
It was held in 2000, 2001in Lancaster PA, USA
In 2003 in Oxford, UK,
In 2004 in Stamford, USA
In 2004 in Ettlingen, Germany
In 2005 in Kona, Hawaii, USA
In 2006 the IWPCPS-8 will be held in Rhodes, Greece at the Sofitel Capsis Hotel Rhodes & Convention Centre " Marika Capsis 2000".
The workshop will allow you to learn in a relaxed environment about in-depth understanding of state-of-the-art physical characterization of pharmaceutical solids.
The program is intended to benefit scientists and researchers in the areas of drug discovery, preformulation, formulation, stability testing, product development, product quality control, and analytical services.
Workshop participants will be exposed to several analytical approaches of characterizing a solid. They will learn how these approaches can complement each other and may be utilized individually or in concert in the solution of real problems in pharmaceutical development and solid-state chemistry.
The workshop
will combine information about modern laboratory techniques to
solve pharmaceutical problems and teaching about solid state characterization
of pharmaceuticals. It will offer fundamental approaches as well
as up-to-date technical information and future outlooks.
Who should attend?
The workshop is designed for scientists, formulators and regulatory
personnel from the following areas:
Pharmaceutical
Research and Development
- Ethical
and Generic Pharmaceutical Production
- Excipient/Chemicals
Production
- Veterinary
Pharmaceutical Manufacturing
- Food Processing
- Compounding
Pharmacists
- Regulatory
Agencies
- Academia
- Analytical
Equipment Manufacturers
- Analytical
Laboratories
June 18-24, 2006
Sofitel Capsis Hotel Rhodes & Convention Centre " Marika Capsis 2000"
Ixia, Rhodes, Greece
We would like to encourage the participants to register before March 10, since the reserved room block is limited.
Click here to get information about registration prices.
On
June 18 & 20,
2006
We are
offering short courses on:
Sunday June 18,
9 AM to 11 AM
- X-RAY POWDER DIFFRACTION IN THE PHARMACEUTICAL INDUSTRY: OPTIMIZING
THE X-RAY OPTICS AND INSTRUMENTATION
Chairperson: Dr. Detlef Beckers,
PANalytical, The Netherlands
|
- XRPD applications in the pharmaceutical industry
- X-ray optical configurations and instrumentation for different applications
- Comparison of beam geometries
|
Sunday June 18,
1 PM to 3 PM
- POLYMORPH SCREENING:
TECHNIQUES AND APPLICATIONS
Chairperson: Marek Zakrzewski, USA
|
- Basic introduction to polymorph screening and
the techniques used
|
Sunday June 18,
3 PM to 5 PM
- CCALIBRATION OF DISSOLUTION EQUIPMENT
AND TROUBLESHOOTING IN PHARMACEUTICAL DISSOLUTION TESTING: A HANDS-ON SHORT COURSE
Chairperson: Dr. Sandra Klein, University of Frankfurt, Germany
Dr. Fank Wucher, ERWEKA, Germany
|
- Mechanical calibration of USP apparatus I, II and III
- Apparatus Suitability test
- Adequate test conditions for USP apparatus I and II
- Adequate test conditions for USP apparatus III
- Preparation of standard solutions
- Filter suitability test
- Adequate preparation of test media (e.g. degassing, test temperature, dosing)
- Sampling
- nterpretation of test results
|
Wednesday June 21,
5 PM to 7 PM
- RAMAN AND MICRO-XRF: SPECTROSCOPIC
PROGRESS IN DRUG DEVELOPMENT
AND PAT APPLICATIONS
Chairperson: Joanna Mason, HORIBA Jobin Yvon, France
|
|
An introduction into how spectroscopy is being used within the modern pharma industry as a tool for drug development and PAT. Process monitoring, HTS, screening and R&D illustrations for Raman and micro XRF will develop the theme of how these newer technologies are being applied in pharmaceutical applications and the advantages that they can bring to industry. What is new and what is evolving for these techniques.
|
No Timing Available Yet!
- NEAR-INFRARED CHEMICAL IMAGING FOR FAST PHYSICAL AND CHEMICAL CHARACTERIZATION OF PHARMACEUTICALS.
Chairperson: Neil Lewis, Spectral Dimensions, USA
|
Near-infrared (NIR) chemical imaging and the development of the instrumentation and software specifically designed to meet the needs of the pharmaceutical industry have revolutionized the way solid dosage forms are characterized.
It is now well understood that the spatial arrangement and physical form of all the chemical moieties in finished pharmaceutical products drive overall product performance. As a result, analytical tools such as NIR chemical imaging that provide insight into these properties have implications and applications in pharmaceutical development, manufacturing root cause analysis, process understanding and quality assurance and quality control.
This short course describes the role that NIR chemical imaging is increasingly taking in assessing the quality of solid dosage forms, understanding manufacturing practices and optimization and in the PAT initiative. Specific examples will be presented on the following topics:
- Identification and spatial distribution of chemical species in solid dosage forms
- Content uniformity
- Understanding controlled release products
- Localization of polymorphic forms in finished products
- Relating chemical images to product performance and manufacturing practices
|
No Timing Available Yet!
- MINIMIZING THE RISK OF MISSING VALUABLE SOLID FORMS
Chairperson: Eva Dova, Aventium Technologies; The Netherlands
|
In various stages of Drug Development one needs to take decisions and select the "best" solid form to continue in the next phase. An overview of those stages and the selection criteria in each case in order to recognize and select a "valuable" solid form will be discussed.
A virtual case study will be presented step by step based on (but not limited to) Rational High-Throughput experimentation. The approach is oriented to reduction of the risk of missing a valuable solid form. A method to tackle the challenge of defining the best conditions of the main influencing parameters (solvent selection, crystallization methods etc) and their limitations will be discussed. The importance of sufficient characterization and the selection of analytical tools will be highlighted. Finally, the results of specific case studies will be presented.
|
Please
register as soon as possible with the online
registration form for the IWPCPS-8, since space is limited.
Scientific Organizing
Committee
Dr.
Angeline Zakrzewski,
assainternational®, USA
Dr.
Frank Leveiller
Director, Astra Zeneca, Sweden
Dr. Leslie Mackin
AstraZeneca, UK
Dr. Steven Byard
Head of Molecular and Physical Characterisation,
Sanofi-Aventis, UK
Dr. John Smoliga
Principal Scientist, Boehringer Ingelheim
Pharmaceutical Inc., USA.
Dr.
Magali Sautel
Solid State Characterization Laboratory Manager
Sanofi Synthelabo, France
Dr.
Peter Sieger
Head of Laboratory Analytical Science
Boehringer Ingelheim, Germany
Dr.
Marek Zakrzewski
USA
Analytical
Instrument
Exhibition
|
A five-day
commercial exhibition
of analytical instrumentation is planned. Interested vendors are
encouraged to make space reservation.
The registration
deadline is March 10!
For more
information please contact assainternational®.
Job
Opportunity Exchange - NEW! |
Starting with our 2004 meeting, assa will be gathering information on positions available with pharmaceutical companies worldwide. Pharmaceutical companies are encouraged to publish their open positions at the workshop. In Britain assa is cooperating with Reed Scientific. For more information on this opportunity please e-mail workshops@assainternational.com.
Corporations
and manufacturers of analytical equipment are welcome to sponsor
this unique workshop. Four levels of sponsorship are available.
For more information please contact assainternational®.
Oral
presentations will last 25 minutes including 5 minutes of discussion. At the
end of each session will be a 30 minutes round table discussion.
assa reserves the right to change the faculty and
agenda to accommodate situations beyond its control.
|
